ATOS
Price
$0.74
Change
-$0.00 (-0.00%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
93.14M
16 days until earnings call
OCGN
Price
$0.56
Change
-$0.05 (-8.20%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
178.19M
52 days until earnings call
Ad is loading...

ATOS vs OCGN

Header iconATOS vs OCGN Comparison
Open Charts ATOS vs OCGNBanner chart's image
Atossa Therapeutics
Price$0.74
Change-$0.00 (-0.00%)
Volume$7.03K
Capitalization93.14M
Ocugen
Price$0.56
Change-$0.05 (-8.20%)
Volume$65.32K
Capitalization178.19M
ATOS vs OCGN Comparison Chart
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. OCGN commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a Hold and OCGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ATOS: $0.74 vs. OCGN: $0.61)
Brand notoriety: ATOS and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 41% vs. OCGN: 71%
Market capitalization -- ATOS: $93.14M vs. OCGN: $178.19M
ATOS [@Biotechnology] is valued at $93.14M. OCGN’s [@Biotechnology] market capitalization is $178.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATOS is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 4 TA indicator(s) are bullish while OCGN’s TA Score has 4 bullish TA indicator(s).

  • ATOS’s TA Score: 4 bullish, 3 bearish.
  • OCGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATOS is a better buy in the short-term than OCGN.

Price Growth

ATOS (@Biotechnology) experienced а -3.67% price change this week, while OCGN (@Biotechnology) price change was -6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

ATOS is expected to report earnings on May 19, 2025.

OCGN is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($178M) has a higher market cap than ATOS($93.1M). ATOS YTD gains are higher at: -21.873 vs. OCGN (-24.199). ATOS has higher annual earnings (EBITDA): -29.46M vs. OCGN (-50.89M). ATOS has more cash in the bank: 74.8M vs. OCGN (38.7M). ATOS has less debt than OCGN: ATOS (0) vs OCGN (6.78M). OCGN has higher revenues than ATOS: OCGN (4.7M) vs ATOS (0).
ATOSOCGNATOS / OCGN
Capitalization93.1M178M52%
EBITDA-29.46M-50.89M58%
Gain YTD-21.873-24.19990%
P/E RatioN/AN/A-
Revenue04.7M-
Total Cash74.8M38.7M193%
Total Debt06.78M-
FUNDAMENTALS RATINGS
ATOS vs OCGN: Fundamental Ratings
ATOS
OCGN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9296
PRICE GROWTH RATING
1..100
8990
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATOS's Valuation (28) in the Medical Specialties industry is somewhat better than the same rating for OCGN (63) in the null industry. This means that ATOS’s stock grew somewhat faster than OCGN’s over the last 12 months.

OCGN's Profit vs Risk Rating (99) in the null industry is in the same range as ATOS (100) in the Medical Specialties industry. This means that OCGN’s stock grew similarly to ATOS’s over the last 12 months.

ATOS's SMR Rating (92) in the Medical Specialties industry is in the same range as OCGN (96) in the null industry. This means that ATOS’s stock grew similarly to OCGN’s over the last 12 months.

ATOS's Price Growth Rating (89) in the Medical Specialties industry is in the same range as OCGN (90) in the null industry. This means that ATOS’s stock grew similarly to OCGN’s over the last 12 months.

ATOS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as OCGN (100) in the null industry. This means that ATOS’s stock grew similarly to OCGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATOSOCGN
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOCY93.092.84
+3.15%
Itochu Corp.
WLDBF1.36N/A
+0.29%
WILDBRAIN LTD.
REPYY12.750.01
+0.08%
Repsol S.A.
SRNW0.12N/A
-0.41%
Stratos Renewables Corp.
HNGKY22.35-1.09
-4.65%
Hongkong Land Holdings Ltd.

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-3.24%
RAIN - OCGN
53%
Loosely correlated
-4.07%
ARRY - OCGN
47%
Loosely correlated
+16.26%
AXON - OCGN
46%
Loosely correlated
+5.43%
AKBA - OCGN
39%
Loosely correlated
-1.04%
ABOS - OCGN
38%
Loosely correlated
+0.81%
More